2Mt plant using KDR's spod concentrate price gives NPV of US$273M
$353 Million NPV
PLS's MC was ~$290mil from memory when they announced their PFS with an NPV of $405mil
![]()
- Forums
- ASX - By Stock
- FFX
- Ann: Presentation to Shareholder Meeting
Ann: Presentation to Shareholder Meeting, page-17
-
- There are more pages in this discussion • 331 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online